Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Glucocorticoid resistance in Crohn's disease and ulcerative colitis: an association study investigating GR and FKBP5 gene polymorphisms

Abstract

The aim of this study is to investigate the role of single-nucleotide polymorphisms (SNPs) of the glucocorticoid receptor (GR) and of the related co-chaperone FKBP5 genes in the development of glucocorticoid (GC) resistance in Crohn's disease (CD) and ulcerative colitis (UC) patients. We have developed a high-resolution DNA melting method that allows simultaneous identification of GR (BclI, N363S and ER22/23EK) and FKBP5 (rs3800373, rs1360780 and rs4713916) polymorphisms. Genotype frequencies were determined in 100 consecutive CD and 100 UC patients under GCs therapy (50 responders and 50 resisters). The variation of FKBP5 polymorphism rs4713916 (G/A), in the putative promoter region of FKBP5, is significantly associated with resistance to GC treatment in CD (responder=17% versus resister=35%; P=0.0043). No significant differences were found in UC patients. If these preliminary findings will be confirmed, the combination of GR and FKBP5 mutational analyses could help to identify subgroups of CD patients with higher chances to benefit from GC treatment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Farrell RJ, Kelleher D . Glucocorticoid resistance in inflammatory bowel disease. J Endocrinol 2003; 178: 339–346.

    Article  CAS  PubMed  Google Scholar 

  2. Barnes PJ, Adcock IM . Glucocorticoid resistance in inflammatory diseases. Lancet 2009; 373: 1905–1917.

    Article  CAS  PubMed  Google Scholar 

  3. Zhang X, Clark AF, Yorio T . FK506-binding protein 51 regulates nuclear transport of the glucocorticoid receptor beta and glucocorticoid responsiveness. Invest Ophthalmol Vis Sci 2008; 49: 1037–1047.

    Article  PubMed  Google Scholar 

  4. Chrousos GP, Renquist D, Brandon D, Eil C, Pugeat M, Vigersky R et al. Glucocorticoid hormone resistance during primate evolution: receptor-mediated mechanisms. Proc Natl Acad Sci USA 1982; 79: 2036–2040.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Denny WB, Valentine DL, Reynolds PD, Smith DF, Scammell JG . Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology 2000; 141: 4107–4113.

    Article  CAS  PubMed  Google Scholar 

  6. Fuller PJ, Smith BJ, Rogerson FM . Cortisol resistance in the New World revisited. Trends Endocrinol Metab 2004; 15: 296–299.

    Article  CAS  PubMed  Google Scholar 

  7. Reynolds PD, Ruan Y, Smith DF, Scammell JG . Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51. J Clin Endocrinol Metab 1999; 84: 663–669.

    CAS  PubMed  Google Scholar 

  8. Wochnik GM, Ruegg J, Abel GA, Schmidt U, Holsboer F, Rein T . FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem 2005; 280: 4609–4616.

    Article  CAS  PubMed  Google Scholar 

  9. Koenen KC, Saxe G, Purcell S, Smoller JW, Bartholomew D, Miller A et al. Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Mol Psychiatry 2005; 10: 1058–1059.

    Article  CAS  PubMed  Google Scholar 

  10. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008; 299: 1291–1305.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Kirchheiner J, Lorch R, Lebedeva E, Seeringer A, Roots I, Sasse J et al. Genetic variants in FKBP5 affecting response to antidepressant drug treatment. Pharmacogenomics 2008; 9: 841–846.

    Article  CAS  PubMed  Google Scholar 

  12. Willour VL, Chen H, Toolan J, Belmonte P, Cutler DJ, Goes FS et al. Family-based association of FKBP5 in bipolar disorder. Mol Psychiatry 2009; 14: 261–268.

    Article  CAS  PubMed  Google Scholar 

  13. Binder EB . The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 2009; 34 (Suppl 1): S186–S195.

    Article  CAS  PubMed  Google Scholar 

  14. Tatro ET, Everall IP, Masliah E, Hult BJ, Lucero G, Chana G et al. Differential expression of immunophilins FKBP51 and FKBP52 in the frontal cortex of HIV-infected patients with major depressive disorder. J Neuroimmune Pharmacol 2009; 4: 218–226.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Zobel A, Schuhmacher A, Jessen F, Hofels S, von WO, Metten M et al. DNA sequence variants of the FKBP5 gene are associated with unipolar depression. Int J Neuropsychopharmacol 2010; 13: 649–660.

    Article  CAS  PubMed  Google Scholar 

  16. Wust S, van Rossum EF, Federenko IS, Koper JW, Kumsta R, Hellhammer DH . Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J Clin Endocrinol Metab 2004; 89: 565–573.

    Article  PubMed  Google Scholar 

  17. Kumsta R, Entringer S, Koper JW, van Rossum EF, Hellhammer DH, Wust S . Sex specific associations between common glucocorticoid receptor gene variants and hypothalamus-pituitary-adrenal axis responses to psychosocial stress. Biol Psychiatry 2007; 62: 863–869.

    Article  CAS  PubMed  Google Scholar 

  18. van Rossum EF, Feelders RA, van den Beld AW, Uitterlinden AG, Janssen JA, Ester W et al. Association of the ER22/23EK polymorphism in the glucocorticoid receptor gene with survival and C-reactive protein levels in elderly men. Am J Med 2004; 117: 158–162.

    Article  CAS  PubMed  Google Scholar 

  19. Ising M, Depping AM, Siebertz A, Lucae S, Unschuld PG, Kloiber S et al. Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur J Neurosci 2008; 28: 389–398.

    Article  PubMed  Google Scholar 

  20. Vermeer H, Hendriks-Stegeman BI, van SD, Rijkers GT, van Buul-Offers SC, Jansen M . An in vitro bioassay to determine individual sensitivity to glucocorticoids: induction of FKBP51 mRNA in peripheral blood mononuclear cells. Mol Cell Endocrinol 2004; 218: 49–55.

    Article  CAS  PubMed  Google Scholar 

  21. Woodruff PG, Boushey HA, Dolganov GM, Barker CS, Yang YH, Donnelly S et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci USA 2007; 104: 15858–15863.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Podolsky DK . Inflammatory bowel disease. N Engl J Med 2002; 347: 417–429.

    Article  CAS  PubMed  Google Scholar 

  23. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl A): 5–36.

    Article  Google Scholar 

  24. Orlando A, Armuzzi A, Papi C, Annese V, Ardizzone S, Biancone L et al. The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: the use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease. Dig Liver Dis 2011; 43: 1–20.

    Article  PubMed  Google Scholar 

  25. Maltese P, Canestrari E, Palma L, Ruzzo A, Corini F, Menotta M et al. High resolution melting (HRM) analysis for the detection of ER22/23EK, BclI, and N363S polymorphisms of the glucocorticoid receptor gene. J Steroid Biochem Mol Biol 2009; 113: 269–274.

    Article  CAS  PubMed  Google Scholar 

  26. Miller SA, Dykes DD, Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Summers RW, Switz DM, Sessions Jr JT, Becktel JM, Best WR, Kern Jr F et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1979; 77: 847–869.

    CAS  PubMed  Google Scholar 

  28. Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H et al. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology 1984; 86: 249–266.

    CAS  PubMed  Google Scholar 

  29. Goebell H, Forster S, Dirks E, Hotz J, Schaarschmidt K, Eigler FW . Crohn disease: clinical disease pattern in relation to site. A prospective analysis of 300 patients]. Med Klin (Munich) 1987; 82: 1–8.

    CAS  Google Scholar 

  30. Goldberg HI, Caruthers Jr SB, Nelson JA, Singleton JW . Radiographic findings of the National Cooperative Crohn's Disease Study. Gastroenterology 1979; 77: 925–937.

    CAS  PubMed  Google Scholar 

  31. Zou YF, Wang F, Feng XL, Li WF, Tao JH, Pan FM et al. Meta-analysis of FKBP5 gene polymorphisms association with treatment response in patients with mood disorders. Neurosci Lett 2010; 484: 56–61.

    Article  CAS  PubMed  Google Scholar 

  32. Hawkins GA, Lazarus R, Smith RS, Tantisira KG, Meyers DA, Peters SP et al. The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroids. J Allergy Clin Immunol 2009; 123: 1376–1383.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Ririe KM, Rasmussen RP, Wittwer CT . Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal Biochem 1997; 245: 154–160.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the patients affected by IBD recruited at IRCCS-‘Casa Sollievo della Sofferenza’ Hospital in San Giovanni Rotondo, Italy, whose altruism and trust in biomedical research have made this study possible. No writing assistance was used in the production of this manuscript. This study was supported by the RC1002GA25 funding from the Italian Minister of Health, granted to the IRCCS-‘Casa Sollievo della Sofferenza’ Hospital; and by PRIN-MIUR funding, granted to the Department of Biomolecular Sciences, University of Urbino.

Author information

Authors and Affiliations

Corresponding author

Correspondence to M Magnani.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maltese, P., Palma, L., Sfara, C. et al. Glucocorticoid resistance in Crohn's disease and ulcerative colitis: an association study investigating GR and FKBP5 gene polymorphisms. Pharmacogenomics J 12, 432–438 (2012). https://doi.org/10.1038/tpj.2011.26

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/tpj.2011.26

Keywords

This article is cited by

Search

Quick links